The phase 3 BLISS-BELIEVE trial provided valuable insights into the efficacy and safety of sequential therapy with subcutaneous belimumab (BEL) and a single cycle of ...
A recent study published in The Journal of Nutritional Biochemistry shed light on the role of selenium (Se) and its associated proteins, Selenoprotein P (SELENOP) and ...
The FOREMOST trial results published in the Annals of the Rheumatic Diseases demonstrated the potential of apremilast in significantly improving outcomes for patients in the ...
A recent study published in Human Molecular Genetics has spotlighted E74-like factor 1 (ELF1) as a potential biomarker for disease activity and renal involvement in ...
In a significant development for rheumatoid arthritis (RA) management, interim results from the long-term FINCH 4 extension study published in Rheumatic and Musculoskeletal Diseases Open ...
A single-blind, randomized controlled trial conducted in A Coruña, Spain, has provided evidence that aquatic therapy (AT) outperforms land-based therapy (LBT) in managing pain and ...
A recent multicenter clinical trial published in JAMA Network has demonstrated that incorporating mycophenolate mofetil (MMF) into the standard treatment regimen significantly reduces the risk ...
A recent study published in Annals of Rheumatic Diseases has revealed pivotal role of the caspase recruitment domain-containing protein 9 (CARD9) /neutrophil signaling axis in ...
Dr. Sampath Rangasamy spoke about the role of inflammation in microvascular diabetic complications. Ang-2 is an important pro-inflammatory and provasopermeability agent in DR ... Read more
Dr. K. Gokulakrishnan discussed the adipose tissue and brain – The neuroinflammatory link. Neuroinflammation appears to be the cornerstone of the different factors contributing ... Read more
 Dr. Chandrashekara. S discussed the Immune-Mechanism of Autoimmune related Inflammatory Diseases of Skin. Skin is not a protective layer but also an active organ ... Read more
Autoimmune-mediated inflammatory skin disorder- introduction to clinical variety was discussed by Dr. Shekhar Neema. Pemphigus group of disorders and urticaria are the B cell ... Read more
Dr. Swaminathan Sethu discussed the immune-mechanism unique to ophthalmic-associated inflammations. The basic mechanism in ocular conditions is that immune privilege to dampen the general inflammation ... Read more
The talk on primary immunodeficiency focuses on recognizing signs like recurrent infections, failure to thrive, and unusual infections for early suspicion. It highlights the need ... Read more
Dr. Chandrashekara. S discussed the use of autoantibodies in the diagnosis of Rheumatic diseases. Monoclonal antibodies have a higher chance of detecting the exact antigen ... Read more
Dr. Chandrashekara. S discussed the precautions before administration of tofacitinib. Jak inhibitors are Pan cytokines blocker that impairs the immune system functioning effectively. Incidence of ... Read more
Dr. Rajkiran Dudam spoke about the tofacitinib indications and their use in rheumatology. Tofacitinib comes with lots of expectations and its generics are widely ... Read more
Dr. Puja Srivastava discussed the concept of JAK inhibitor utility in the management of autoimmune diseases. Activation of the JAK-STAT Signal transduction pathway is a ... Read more
Dr. Namita Dave discussed the imaging in uveitis: the bigger picture on inflammation. The methods used in the anterior eye segment imaging are slit ... Read more
Dr. Roshmi Gupta discussed orbital inflammation and the perspective of an ophthalmologist. Orbital inflammation is a proptosed, and painful red eye, with reduced ocular ... Read more
Dr. Sanjay S spoke about intermediate uveitis. Inflammation in the vitreous humor, ciliary body, or peripheral retina is known as intermediate uveitis. Treatment of ... Read more
Dr. Padmamalini discussed the clinical clues in the differential diagnosis of anterior uveitis. A detailed history and a thorough clinical examination remain the ... Read more
Clinical evaluation of episcleritis & scleritis and interpretation of the differential diagnosis of episcleritis and scleritis were discussed by Dr. Ankush. AS- angiography helps ... Read more
The phase 3 BLISS-BELIEVE trial provided valuable insights into the efficacy and safety of sequential therapy with subcutaneous belimumab (BEL) and a single cycle of ... Read more
A recent study published in The Journal of Nutritional Biochemistry shed light on the role of selenium (Se) and its associated proteins, Selenoprotein P (SELENOP) and ... Read more
The FOREMOST trial results published in the Annals of the Rheumatic Diseases demonstrated the potential of apremilast in significantly improving outcomes for patients in the ... Read more
A recent study published in Human Molecular Genetics has spotlighted E74-like factor 1 (ELF1) as a potential biomarker for disease activity and renal involvement in ... Read more
In a significant development for rheumatoid arthritis (RA) management, interim results from the long-term FINCH 4 extension study published in Rheumatic and Musculoskeletal Diseases Open ... Read more
A single-blind, randomized controlled trial conducted in A Coruña, Spain, has provided evidence that aquatic therapy (AT) outperforms land-based therapy (LBT) in managing pain and ... Read more
